{"id":42088,"date":"2021-09-21T15:10:01","date_gmt":"2021-09-21T21:10:01","guid":{"rendered":"https:\/\/www.uchealth.org\/today\/?p=42088"},"modified":"2024-12-24T09:00:53","modified_gmt":"2024-12-24T16:00:53","slug":"treatment-for-covid-19-has-progressed-but-vaccines-still-paramount","status":"publish","type":"post","link":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/","title":{"rendered":"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount"},"content":{"rendered":"
<\/div>

The coronavirus pandemic has been about change. The virus has mutated, occasionally in unpleasant ways. Some of the best vaccines ever created have changed our most potent front-line defenses from distancing and masking to jabs in nearly six billion shoulders and counting. But what about the treatment of those who end up sick with COVID-19?<\/p>\n

\"a
The treatment for COVID-19 – monoclonal antibodies prescribed to her as an outpatient – seem to have knocked back Juliette Morrow\u2019s breakthrough coronavirus infection. Photo by Cyrus McCrimmon for UCHealth.<\/figcaption><\/figure>\n

Given the lofty hospitalization numbers<\/a> in Colorado and, much more so, in Texas and across the southern United States, it might not look like the treatment for COVID-19 has changed all that much in the past year or so.<\/p>\n

The big improvements in care involved the steroid dexamethasone<\/a> and the antiviral remdesivir<\/a> becoming standard treatments for hospitalized coronavirus patients in mid-2020 and the Regeneron monoclonal antibody<\/a> cocktail\u2019s emergence<\/a> that fall. But, in fact, treatment for COVID-19 has improved, if more incrementally than vaccine-fueled prevention.<\/p>\n

The case of Juliette Morrow offers an example of how. Morrow, 61, had been fully vaccinated for months when, after a family gathering in Texas in late July, sniffles became congestion, her headache grew unrelenting, and a fever and nasty cough persisted. Back home in Denver, she tested positive for the coronavirus on a Friday. As Morrow\u2019s physician at UCHealth Internal Medicine \u2013 Anschutz Medical Campus<\/a>, Dr. Mindy Lam<\/a> of the University of Colorado School of Medicine, was checking in on test results, she saw the breakthrough COVID-19 test. She called her patient.

Research and guidelines around monoclonal antibody therapy continue to evolve as new variants of COVID-19 emerge. Please check\u00a0here\u00a0<\/a>for the latest update on monoclonal antibody therapy at UCHealth.<\/div>\n

New treatment options for COVID-19<\/strong><\/h2>\n

A year ago, there would have been nothing to do but watch, wait, and hope. Now there was an alternative: based on an expanded<\/a> U.S. Food and Drug Administration approval and state of Colorado guidelines, UCHealth can administer the aforementioned Regeneron monoclonal antibody cocktail \u2013 a combination of casirivimab and imdevimab called REGEN-COV \u2013 to certain outpatients. (The combination of bamlanivimab and etesevimab<\/a> and the solo monoclonal antibody sotrovimab<\/a> have also been FDA-approved for outpatients.) These are all lab-produced proteins that hook onto coronavirus-causing SARS-CoV-2 viruses and keep them from invading human cells.<\/p>\n

\"Dr.
Dr. Mindy Lam<\/figcaption><\/figure>\n

A subsequent<\/a> FDA emergency use authorization expanded the use of REGEN-COV to certain high-risk patients who had merely been exposed to COVID-19 in the past 10 days. But UCHealth follows state of Colorado rules<\/a> that limit REGEN-COV to those showing symptoms in that time frame and who are at high risk of developing severe COVID-19.<\/p>\n

Among the risk factors include being 65 or older, pregnancy, chronic kidney disease, diabetes, immunosuppression, cardiovascular disease, and chronic lung disease. Morrow\u2019s cardiovascular disease qualified her, Lam recognized, and suggested REGEN-COV. The patient agreed that it was a good idea, and Lam signed her up though a state website<\/a>. (Those lacking a primary care provider can sign up here<\/a> for virtual visits through UCHealth Virtual Urgent Care.)<\/p>\n

On the upswing<\/strong><\/h2>\n

The following Monday, Morrow sat in an infusion chair at UCHealth Broomfield Hospital<\/a>, one of about 30 sites<\/a> statewide offering REGEN-COV infusions. It\u2019s free for patients thanks to the federal government spending<\/a> about $2,100 per dose. About an hour and a half later, of which 20 minutes constituted the actual monoclonal antibody infusion, Morrow was on her way. One can\u2019t know whether REGEN-COV is to thank. But, Morrow says, after days of feeling miserable, \u201cI felt like I was on the upswing by the next day or two. I worked from home that week.\u201d<\/p>\n

Among the others at that Texas family gathering who fell ill with COVID-19 included Morrow\u2019s mother-in-law. Also vaccinated, she\u2019s 85, and her COPD<\/a> has her on oxygen to start with, Morrow says. The family feared the worst. But she also got a REGEN-COV infusion and pulled through. Lam, who has prescribed REGEN-COV to several patients since early August, is a strong proponent of monoclonal antibodies for her high-risk patients. \u201cI think it\u2019s great,\u201d she said. \u201cIt\u2019s helpful to have an outpatient treatment (for COVID-19) that can potentially prevent hospitalization and severe disease.\u201d<\/p>\n

New inpatient-care options for treating COVID-19<\/strong><\/h2>\n
\"Dr.
Dr. Thomas Campbell<\/figcaption><\/figure>\n

Patients sick enough to be hospitalized also have more options than a year ago, says Dr. Thomas Campbell<\/a>, a CU School of Medicine and UCHealth virologist and infectious-disease specialist. As before, he says, the antiviral remdesivir and the steroid dexamethasone remain cornerstone inpatient treatment for COVID-19.<\/p>\n

The REGEN-COV that Lam prescribed Morrow, in contrast, has shown little benefit to seriously ill patients and rarely given to UCHealth inpatients. The understanding that an immune response gone haywire<\/a> is often at play in serious coronavirus cases has added immune-system modulators to the inpatient and ICU armamentarium. Campbell says they come into play when patients get worse despite receiving remdesivir and dexamethasone. These drugs include IL-6 receptor antagonists such as tocilizumab and sarilumab<\/a>. Those who can\u2019t tolerate or don\u2019t respond to IL-6 receptor antagonists may receive a Janus kinase inhibitor<\/a> such as baricitinib, he says.<\/p>\n

Despite better inpatient treatment for COVID-19, hospital stays for serious cases tend to be long and the recoveries difficult. Campbell is far from alone in advising a far more efficient means of harnessing the medical advances of the past 18 months. \u201cWe talk about monoclonal antibodies like the Regeneron combination being helpful. But the thing that is most helpful, the thing that is most effective in keeping people from getting sick enough to be hospitalized, is vaccination,\u201d he said. \u201cThe vast majority<\/a> of people who are admitted to our hospitals are people who are not vaccinated.\u201d<\/p>\n

\"Juliette
Juliette Morrow<\/figcaption><\/figure>\n

Morrow has fully recovered. She feels that, while the monoclonal antibodies may have helped and highly recommends the treatment to those who find themselves in her position, the coronavirus vaccine was decisive in her body\u2019s ability to fight off the disease\u2019s worst outcomes. \u201cI don\u2019t know how I would have reacted had I not been vaccinated,\u201d she said.<\/p>\n","protected":false},"excerpt":{"rendered":"

The coronavirus pandemic has been about change. The virus has mutated, occasionally in unpleasant ways. Some of the best vaccines ever created have changed our most potent front-line defenses from distancing and masking to jabs in nearly six billion shoulders and counting. But what about the treatment of those who end up sick with COVID-19? […]<\/p>\n","protected":false},"author":23,"featured_media":42090,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[6],"tags":[4859,4860,9069,162],"class_list":["post-42088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthy-living","tag-coronavirus","tag-covid-19","tag-covid-19-vaccine","tag-infectious-diseases"],"acf":[],"yoast_head":"\nTreatment for COVID-19 has progressed - UCHealth Today<\/title>\n<meta name=\"description\" content=\"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount\" \/>\n<meta property=\"og:description\" content=\"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\" \/>\n<meta property=\"og:site_name\" content=\"UCHealth Today\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/uchealthorg\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-21T21:10:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-24T16:00:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.jpg\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Todd Neff, for UCHealth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uchealth\" \/>\n<meta name=\"twitter:site\" content=\"@uchealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Todd Neff, for UCHealth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\"},\"author\":{\"name\":\"Todd Neff, for UCHealth\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/da7733ff5562e48e55c027d111ee5911\"},\"headline\":\"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount\",\"datePublished\":\"2021-09-21T21:10:01+00:00\",\"dateModified\":\"2024-12-24T16:00:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\"},\"wordCount\":1080,\"publisher\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp\",\"keywords\":[\"coronavirus\",\"COVID-19\",\"COVID-19 vaccine\",\"Infectious diseases\"],\"articleSection\":[\"Healthy living\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\",\"url\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\",\"name\":\"Treatment for COVID-19 has progressed - UCHealth Today\",\"isPartOf\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp\",\"datePublished\":\"2021-09-21T21:10:01+00:00\",\"dateModified\":\"2024-12-24T16:00:53+00:00\",\"description\":\"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage\",\"url\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp\",\"contentUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp\",\"width\":1200,\"height\":795,\"caption\":\"Monoclonal antibodies prescribed to her as an outpatient seem to have knocked back Juliette Morrow\u2019s breakthrough coronavirus infection. Photo by Cyrus McCrimmon for UCHealth.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.uchealth.org\/today\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#website\",\"url\":\"https:\/\/www.uchealth.org\/today\/\",\"name\":\"UCHealth Today\",\"description\":\"UCHealth Today\",\"publisher\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.uchealth.org\/today\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#organization\",\"name\":\"UCHealth\",\"url\":\"https:\/\/www.uchealth.org\/today\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg\",\"contentUrl\":\"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg\",\"width\":1000,\"height\":1000,\"caption\":\"UCHealth\"},\"image\":{\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/uchealthorg\/\",\"https:\/\/x.com\/uchealth\",\"https:\/\/www.instagram.com\/uchealth\/\",\"https:\/\/www.linkedin.com\/school\/14839\/\",\"https:\/\/www.pinterest.com\/uchealthorg\/\",\"https:\/\/www.youtube.com\/channel\/UC41SJI79yjZIe96OajzN22g\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/da7733ff5562e48e55c027d111ee5911\",\"name\":\"Todd Neff, for UCHealth\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g\",\"caption\":\"Todd Neff, for UCHealth\"},\"description\":\"Todd Neff has written hundreds of stories for University of Colorado Hospital and UCHealth. He covered science and the environment for the Daily Camera in Boulder, Colorado, and has taught narrative nonfiction at the University of Colorado, where he was a Ted Scripps Fellowship recipient in Environmental Journalism. He is author of \u201cA Beard Cut Short,\u201d a biography of a remarkable professor; \u201cThe Laser That\u2019s Changing the World,\u201d a history of lidar; and \u201cFrom Jars to the Stars,\u201d a history of Ball Aerospace.\",\"url\":\"https:\/\/www.uchealth.org\/today\/author\/tneff\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Treatment for COVID-19 has progressed - UCHealth Today","description":"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/","og_locale":"en_US","og_type":"article","og_title":"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount","og_description":"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.","og_url":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/","og_site_name":"UCHealth Today","article_publisher":"https:\/\/www.facebook.com\/uchealthorg\/","article_published_time":"2021-09-21T21:10:01+00:00","article_modified_time":"2024-12-24T16:00:53+00:00","og_image":[{"url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.jpg","type":"image\/jpeg"}],"author":"Todd Neff, for UCHealth","twitter_card":"summary_large_image","twitter_creator":"@uchealth","twitter_site":"@uchealth","twitter_misc":{"Written by":"Todd Neff, for UCHealth","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#article","isPartOf":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/"},"author":{"name":"Todd Neff, for UCHealth","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/da7733ff5562e48e55c027d111ee5911"},"headline":"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount","datePublished":"2021-09-21T21:10:01+00:00","dateModified":"2024-12-24T16:00:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/"},"wordCount":1080,"publisher":{"@id":"https:\/\/www.uchealth.org\/today\/#organization"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage"},"thumbnailUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp","keywords":["coronavirus","COVID-19","COVID-19 vaccine","Infectious diseases"],"articleSection":["Healthy living"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/","url":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/","name":"Treatment for COVID-19 has progressed - UCHealth Today","isPartOf":{"@id":"https:\/\/www.uchealth.org\/today\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage"},"thumbnailUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp","datePublished":"2021-09-21T21:10:01+00:00","dateModified":"2024-12-24T16:00:53+00:00","description":"Treatment for COVID-19 has progressed with outpatient monoclonal antibodies and inpatient IL-6 receptor antagonists.","breadcrumb":{"@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#primaryimage","url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp","contentUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2021\/09\/21142424\/UCHealth_JulietteMorrow0001.jpgtiny.webp","width":1200,"height":795,"caption":"Monoclonal antibodies prescribed to her as an outpatient seem to have knocked back Juliette Morrow\u2019s breakthrough coronavirus infection. Photo by Cyrus McCrimmon for UCHealth."},{"@type":"BreadcrumbList","@id":"https:\/\/www.uchealth.org\/today\/treatment-for-covid-19-has-progressed-but-vaccines-still-paramount\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.uchealth.org\/today\/"},{"@type":"ListItem","position":2,"name":"Treatment for those sick with COVID-19 have progressed, but vaccines still paramount"}]},{"@type":"WebSite","@id":"https:\/\/www.uchealth.org\/today\/#website","url":"https:\/\/www.uchealth.org\/today\/","name":"UCHealth Today","description":"UCHealth Today","publisher":{"@id":"https:\/\/www.uchealth.org\/today\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.uchealth.org\/today\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.uchealth.org\/today\/#organization","name":"UCHealth","url":"https:\/\/www.uchealth.org\/today\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/","url":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg","contentUrl":"https:\/\/uchealth-wp-uploads.s3.amazonaws.com\/wp-content\/uploads\/sites\/6\/2020\/04\/24135149\/UCHealth-square-logo-1000x1000-1.jpg","width":1000,"height":1000,"caption":"UCHealth"},"image":{"@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/uchealthorg\/","https:\/\/x.com\/uchealth","https:\/\/www.instagram.com\/uchealth\/","https:\/\/www.linkedin.com\/school\/14839\/","https:\/\/www.pinterest.com\/uchealthorg\/","https:\/\/www.youtube.com\/channel\/UC41SJI79yjZIe96OajzN22g"]},{"@type":"Person","@id":"https:\/\/www.uchealth.org\/today\/#\/schema\/person\/da7733ff5562e48e55c027d111ee5911","name":"Todd Neff, for UCHealth","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba17a8f1358d39c104ff6cb59da7fe21b9bfc792948447c3ac964e93b37aa49f?s=96&d=mm&r=g","caption":"Todd Neff, for UCHealth"},"description":"Todd Neff has written hundreds of stories for University of Colorado Hospital and UCHealth. He covered science and the environment for the Daily Camera in Boulder, Colorado, and has taught narrative nonfiction at the University of Colorado, where he was a Ted Scripps Fellowship recipient in Environmental Journalism. He is author of \u201cA Beard Cut Short,\u201d a biography of a remarkable professor; \u201cThe Laser That\u2019s Changing the World,\u201d a history of lidar; and \u201cFrom Jars to the Stars,\u201d a history of Ball Aerospace.","url":"https:\/\/www.uchealth.org\/today\/author\/tneff\/"}]}},"coauthors":[{"id":23,"name":"Todd Neff","link":"https:\/\/www.uchealth.org\/today\/author\/tneff\/"}],"_links":{"self":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/42088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/comments?post=42088"}],"version-history":[{"count":10,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/42088\/revisions"}],"predecessor-version":[{"id":79648,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/posts\/42088\/revisions\/79648"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/media\/42090"}],"wp:attachment":[{"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/media?parent=42088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/categories?post=42088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.uchealth.org\/today\/wp-json\/wp\/v2\/tags?post=42088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}